Francesco Forconi

Professor Francesco Forconi is a leading clinician-scientist at the University of Southampton, UK. Internationally recognized for his clinical and scientific work on B-cell cancers, including HCL. He leads the Southampton designated Center of Excellence for HCL and contributes to UK and international guidelines on HCL diagnosis and management. He leads the Cancer B-cell Group, investigating novel therapeutic approaches against the survival signals mediated by the essential B-cell receptor and BCL2 in B-cell cancers, including HCL. He is the UK lead for the CRUK ECRIN-M3 consortium on early cancer interception. With over 180 peer-reviewed publications, Francesco has spearheaded numerous interventional and observational clinical trials and collaborates closely with patient advocacy groups to enhance care and data platforms. His leadership spans academic, clinical, and policy domains, including roles in NICE appraisals, editorial boards, and cancer science forums.